Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment. Golob-Schwarzl N, Pilic J, Benezeder T, Bordag N, et al. J Invest Dermatol 2024;144:500-508.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Golob-Schwarzl N, Pilic J, Benezeder T, Bordag N, et al. Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment. J Invest Dermatol 2024;144:500-508.
PMID: 37865179